We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+13.12%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$23.6B
AUM Growth
+$1.71B
Cap. Flow
-$406M
Cap. Flow %
-1.72%
Top 10 Hldgs %
52.37%
Holding
196
New
43
Increased
37
Reduced
38
Closed
21

Top Buys

Rank Stock Value
1
HES
Hess
HES
+$502M
2
UNH icon
UnitedHealth
UNH
+$254M
3
ABNB icon
Airbnb
ABNB
+$243M
4
AON icon
Aon
AON
+$196M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$152M

Top Sells

Rank Stock Value
1
CHTR icon
Charter Communications
CHTR
+$311M
2
TMO icon
Thermo Fisher Scientific
TMO
+$228M
3
BX icon
Blackstone
BX
+$222M
4
TRU icon
TransUnion
TRU
+$203M
5
SPLK
Splunk Inc
SPLK
+$202M

Sector Composition

Rank Sector Weight
1 Healthcare 26.88%
2 Technology 10.2%
3 Financials 8.76%
4 Energy 8.1%
5 Industrials 5.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VTYX
76
DELISTED
Ventyx Biosciences
VTYX
$17.4M 0.07%
+3,170,000
New +$14.5M
ZYME icon
77
Zymeworks
ZYME
$1.67B
$16.8M 0.07%
1,601,000
-155,000
-9% -$1.72M
ASND icon
78
Ascendis Pharma A/S
ASND
$16.8B
$16.5M 0.07%
+109,000
New +$15.6M
ITCI
79
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$16M 0.07%
+231,000
New +$15.9M
AXNX
80
DELISTED
Axonics, Inc. Common Stock
AXNX
$15.5M 0.07%
+225,000
New +$15.2M
TAL icon
81
TAL Education Group
TAL
$6.87B
$15.5M 0.07%
1,365,000
– –
RNAM
82
DELISTED
Avidity Biosciences
RNAM
$15.5M 0.07%
+606,061
New +$9.5M
IMNM icon
83
Immunome
IMNM
$2.83B
$14.7M 0.06%
+594,000
New +$12.1M
MGX icon
84
Metagenomi Therapeutics
MGX
$46.3M
$14.2M 0.06%
+1,343,201
New +$15.4M
PACB icon
85
Pacific Biosciences
PACB
$370M
$14.1M 0.06%
3,772,452
-2,418,918
-39% -$14.2M
SVRA icon
86
Savara
SVRA
$1.19B
$11.9M 0.05%
2,394,299
-3,861,107
-62% -$18.7M
QTRX icon
87
Quanterix
QTRX
$190M
$11.1M 0.05%
471,000
+287,000
+156% +$7.11M
SCRM
88
DELISTED
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
$10.7M 0.05%
1,000,000
– –
ROIV icon
89
Roivant Sciences
ROIV
$26.2B
$9.47M 0.04%
898,600
-6,437,400
-88% -$69.4M
RIO icon
90
Rio Tinto
RIO
$164B
$8.76M 0.04%
137,500
– –
CZOO
91
DELISTED
Cazoo Group Ltd
CZOO
$8.57M 0.04%
714,240
– –
BRKR icon
92
Bruker
BRKR
$8.14B
$7.81M 0.03%
83,100
+80,100
+2,670% +$6.44M
GOSS icon
93
Gossamer Bio
GOSS
$87M
$7.23M 0.03%
6,130,272
– –
CYTK icon
94
Cytokinetics
CYTK
$10.4B
$7.18M 0.03%
102,400
-985,372
-91% -$76.2M
BBOT
95
BridgeBio Oncology
BBOT
$747M
$6.21M 0.03%
+600,000
New +$6.21M
NVAX icon
96
Novavax
NVAX
$1.31B
$5.41M 0.02%
+1,131,000
New +$5.25M
PRME icon
97
Prime Medicine
PRME
$559M
$5.25M 0.02%
+750,000
New +$5.69M
ALT icon
98
Altimmune
ALT
$599M
$4.78M 0.02%
470,000
+436,000
+1,282% +$4.43M
GDS icon
99
GDS Holdings
GDS
$6.41B
$4.72M 0.02%
+710,000
New +$4.81M
RARE icon
100
Ultragenyx Pharmaceutical
RARE
$2.55B
$4.62M 0.02%
+99,000
New +$4.67M
2 3
4
5 6

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Farallon Capital Management held 196 positions worth $23.6B, up 7.8% from $21.9B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Farallon Capital Management's Q1 2024 filing shows 43 new, 37 increased, 38 reduced and 21 closed positions. Its largest new stake was Airbnb: 1,608,220 shares worth $265M. The largest sale was Charter Communications, an estimated $311M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

  • Farallon Capital Management's largest Q1 2024 buy was Airbnb: 1,608,220 shares worth $265M.
  • Farallon Capital Management added most to Hess in Q1 2024, an estimated $502M increase.
  • Farallon Capital Management's biggest Q1 2024 reduction was Thermo Fisher Scientific, cutting an estimated $228M.
  • Farallon Capital Management fully exited Charter Communications in Q1 2024, selling an estimated $311M.
  • Farallon Capital Management's ten largest holdings make up 52% of its $23.6B portfolio in Q1 2024.
  • Farallon Capital Management opened 43 new positions and closed 21 in Q1 2024.
  • Farallon Capital Management's portfolio value rose 7.8% quarter-over-quarter to $23.6B.

Based on Farallon Capital Management's 13F filing for Q1 2024, filed 15 May 2024.